Central nervous system involvement by mantle cell lymphoma.
BTK inhibitors
Non-Hodgkin lymphoma
brain
treatment
Journal
Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
pubmed:
24
11
2022
medline:
22
2
2023
entrez:
23
11
2022
Statut:
ppublish
Résumé
Involvement of the central nervous system (CNS) is a rare complication of mantle cell lymphoma (MCL) with limited treatment options. We report the outcomes of 36 patients with CNS involvement compared to 72 matched control MCL patients without CNS involvement. Four patients (11%) with CNS MCL were diagnosed with CNS involvement at time of MCL diagnosis. Median OS from MCL diagnosis was 50.3 months (95% CI: 22.8-79.6) for the CNS MCL group compared to 97.1 months (95% CI: 82.8-NR;
Identifiants
pubmed: 36416595
doi: 10.1080/10428194.2022.2148211
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
371-377Commentaires et corrections
Type : CommentIn